Xinghao Ai, Aiping Zhou, Lin Wu, Zhengbo Song, Zhihua Li, Heshui Wu, Ying Yuan, Hong Zong, Lingjun Zhu, Haitao Zhao, Yuping Sun, Zuoxing Niu, Yu Wang, Haige Shen, Huaqiang Zhu, Chanli Zheng, Shuang Wang, Congqiao Zhao, Zhao Cui, Shun Lu. "A first-in-human phase I/II study of GFH375, a highly selective and potent oral KRAS G12D inhibitor in patients with KRAS G12D mutant advanced solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3013